Alphabetical list:
A B C D E F G H I J K L M N O P R S T U V W X Y Q Z 1 2 3 4 5 6 7 8 9
News: December 1, 2009
Ecstasy Users at Higher Risk of Sleep Apnea
December 1, 2009The widely used club drug ecstasy appears to increase the risk of sleep apnea, say U.S. researchers.
"People who use ecstasy need to know that this drug damages the brain and can cause immediate and dangerous problems such as sleep apnea," study author Dr. Una McCann, of the Johns Hopkins School of Medicine in Baltimore, said in a news release.
McCann and colleagues conducted sleep tests on 71 people who'd used ecstasy (MDMA) and 62 people who'd never used the illegal drug. Ecstasy users had a more than eight-fold increased risk of sleep apnea compared to non-users. Mild sleep apnea rates were similar in both groups (21 percent of ecstasy users and 27 percent of non-users), but only ecstasy users had moderate (13 percent) or severe (1 percent) sleep apnea.
The longer a person used ecstasy, the more sleep apnea episodes they experienced, said the researchers. They also found that ecstasy use was a greater risk factor for sleep apnea than obesity.
"Our findings may be explained by how ecstasy damages neurons related to serotonin, a chemical in the brain that is involved in sleep regulation and breathing, among other important functions," McCann said. "Sleep apnea in itself is dangerous, but it can also contribute to thinking problems in people who use ecstasy because chronic sleep disruption is known to have a negative effect on how a person functions during the daytime."
Archive issues: (50)
Archive list: 1 2 3 4 5 6 7 [8] 9 10 11 12 13 14 15 16 17
November 23, 2009 | Genetic Variant Slows AIDS ProgressionScientists report that a genetic variation appears to play a major role in slowing disease progression in HIV-infected patients. In fact, those with the variation appear to take years longer to develop AIDS and die of complications of the disease. "We're honing in on factors that vary across individuals that make a person more or less susceptible to HIV, in ...
November 22, 2009 | FDA To Reduce the Misuse of MedicationsThe FDA wants to reduce the misuse of medications, saying that at least 50,000 hospitalizations a year could be prevented if physicians, pharmacists, patients and parents would be more careful. And the cost of these preventable injuries is estimated at about $4 billion annually by the Institute of Medicine. FDA commissioner Margaret A. Hamburg ...
November 21, 2009 | Diabetes Drug Byetta Linked to Kidney ProblemsThe FDA has received 78 reports of kidney problems related to Byetta, a drug by Amylin Pharmaceuticals and Eli-Lilly prescribed to treat type 2 diabetes. With the new findings, the drug's label will be updated to warn doctors and patients about this possible side effect. Byetta (exenatide) was approved in 2005. It's known as an incretin mimetic, which copies the action of incretin GLP-1, a hormone that is released in response to ...
Related articles:
Treatment - medication (bladder coatings)
Other bladder coating therapies include Cystistat (sodium hyaluronate) and Uracyst (chondroitin). They are believed to replace the deficient GAG layer on the bladder wall. Like most other intravesical bladder treatments, this treatment may require the patient to lie for 20 - 40 minutes, turning over every ten minutes, to allow the chemical to 'soak in' and give a good coating, before it is passed out with the urine.Section: Interstitial cystitis
Causes
The cause of IC/PBS is unknown, though several theories have been put forward (these include autoimmune, neurologic, allergic and genetic). Regardless of the origin, it is clear that the majority of IC/PBS patients struggle with a damaged urothelium, or bladder lining. When the surface glycosaminoglycan (GAG) layer is damaged (via a urinary tract infection (UTI), excessive consumption of coffee or sodas, traumatic injury, etc.), urinary chemicals can "leak" into surrounding tissues, ...Section: Interstitial cystitis
Chronic prostatitis/chronic pelvic pain syndrome - physical and psychological therapy
For chronic nonbacterial prostatitis (Cat III), also known as CP/CPPS, which makes up the majority of men diagnosed with "prostatitis", a treatment called the "Wise-Anderson Protocol" (aka the "Stanford Protocol"), has recently been published. This is a combination of: Medication (using tricyclic antidepressants and ...Section: Prostatitis